{"id":"https://openalex.org/W2028964482","doi":"https://doi.org/10.1128/aac.00329-06","title":"Randomized, Open-Label, Comparative Study of Piperacillin-Tazobactam Administered by Continuous Infusion versus Intermittent Infusion for Treatment of Hospitalized Patients with Complicated Intra-Abdominal Infection","display_name":"Randomized, Open-Label, Comparative Study of Piperacillin-Tazobactam Administered by Continuous Infusion versus Intermittent Infusion for Treatment of Hospitalized Patients with Complicated Intra-Abdominal Infection","alternate_titles":[],"publication_year":2006,"publication_date":"2006-10-25","ids":{"openalex":"https://openalex.org/W2028964482","doi":"https://doi.org/10.1128/aac.00329-06","mag":"2028964482","pmid":"https://pubmed.ncbi.nlm.nih.gov/16940077","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1635208"},"language":"en","primary_location":{"id":"doi:10.1128/aac.00329-06","doi":"https://doi.org/10.1128/aac.00329-06","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.00329-06","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2028964482"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC1635208","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084126397","display_name":"William K. K. Lau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104115","display_name":"Queen's Medical Center","ror":"https://ror.org/016gbn942","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104115"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"William\u2009K. Lau","raw_affiliation_strings":["The Queens Medical Center, Honolulu, Hawaii"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Queens Medical Center, Honolulu, Hawaii","institution_ids":["https://openalex.org/I4210104115"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Mercer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Mercer","raw_affiliation_strings":["University of Texas, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas, Houston, Texas","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110873768","display_name":"Kamal M.F. Itani","orcid":"https://orcid.org/0000-0003-2477-0264","observed_orcids":["https://orcid.org/0000-0003-2477-0264"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kamal M. Itani","raw_affiliation_strings":["Boston VA Health Care System and Boston University, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston VA Health Care System and Boston University, Boston, Massachusetts","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090740872","display_name":"David P. Nicolau","orcid":"https://orcid.org/0000-0002-4148-0165","observed_orcids":["https://orcid.org/0000-0002-4148-0165"]},"institutions":[{"id":"https://openalex.org/I1302163369","display_name":"Hartford Hospital","ror":"https://ror.org/00gt5xe03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302163369"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David P. Nicolau","raw_affiliation_strings":["Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut","institution_ids":["https://openalex.org/I1302163369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090657231","display_name":"Joseph L. Kuti","orcid":"https://orcid.org/0000-0002-4464-3126","observed_orcids":["https://orcid.org/0000-0002-4464-3126"]},"institutions":[{"id":"https://openalex.org/I1302163369","display_name":"Hartford Hospital","ror":"https://ror.org/00gt5xe03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302163369"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joseph L. Kuti","raw_affiliation_strings":["Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut","institution_ids":["https://openalex.org/I1302163369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015418443","display_name":"Debra L. Mansfield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Debra Mansfield","raw_affiliation_strings":["Wyeth Pharmaceuticals, Collegeville, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Pharmaceuticals, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113587311","display_name":"Adrian Dana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Adrian Dana","raw_affiliation_strings":["Wyeth Pharmaceuticals, Collegeville, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Pharmaceuticals, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4403928396"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5084126397"],"corresponding_institution_ids":["https://openalex.org/I4210104115"],"apc_list":null,"apc_paid":null,"fwci":4.2344,"has_fulltext":false,"cited_by_count":150,"citation_normalized_percentile":{"value":0.94150943,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"50","issue":"11","first_page":"3556","last_page":"3561"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11080","display_name":"Surgical site infection prevention","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/piperacillin-tazobactam","display_name":"piperacillin-tazobactam","score":1.0},{"id":"https://openalex.org/keywords/continuous-infusion","display_name":"continuous infusion","score":0.9819999933242798},{"id":"https://openalex.org/keywords/intermittent-infusion","display_name":"intermittent infusion","score":0.9950000047683716},{"id":"https://openalex.org/keywords/complicated-intra-abdominal-infections","display_name":"complicated intra-abdominal infections","score":0.9710000157356262},{"id":"https://openalex.org/keywords/antibiotic-dosing-regimens","display_name":"antibiotic dosing regimens","score":0.6050000190734863},{"id":"https://openalex.org/keywords/bacteriological-response","display_name":"bacteriological response","score":0.7739999890327454},{"id":"https://openalex.org/keywords/clinical-cure","display_name":"clinical cure","score":0.7110000252723694},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.7480000257492065},{"id":"https://openalex.org/keywords/drug-related-adverse-events","display_name":"drug-related adverse events","score":0.7480000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9420911073684692},{"id":"https://openalex.org/C2777858937","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Piperacillin/tazobactam","level":5,"score":0.7863989472389221},{"id":"https://openalex.org/C2778266534","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Tazobactam","level":5,"score":0.6973783373832703},{"id":"https://openalex.org/C2778193466","wikidata":"https://www.wikidata.org/wiki/Q423787","display_name":"Piperacillin","level":4,"score":0.6364508867263794},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5911526679992676},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5518831610679626},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4974663555622101},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.48091909289360046},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35636091232299805},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000005","descriptor_name":"Abdomen","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":true},{"descriptor_ui":"D000078142","descriptor_name":"Tazobactam","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010397","descriptor_name":"Penicillanic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010397","descriptor_name":"Penicillanic Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010397","descriptor_name":"Penicillanic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010397","descriptor_name":"Penicillanic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010406","descriptor_name":"Penicillins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010406","descriptor_name":"Penicillins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010406","descriptor_name":"Penicillins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018806","descriptor_name":"APACHE","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1128/aac.00329-06","doi":"https://doi.org/10.1128/aac.00329-06","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.00329-06","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:402905","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC1635208","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:1635208","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1635208/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:16940077","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16940077","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Comparative Study"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:402905","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC1635208","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W389831277","https://openalex.org/W1838962315","https://openalex.org/W1972858790","https://openalex.org/W1978397220","https://openalex.org/W1980701181","https://openalex.org/W2000731473","https://openalex.org/W2014460727","https://openalex.org/W2025760535","https://openalex.org/W2033080849","https://openalex.org/W2033437852","https://openalex.org/W2043211447","https://openalex.org/W2046526279","https://openalex.org/W2048101866","https://openalex.org/W2059796351","https://openalex.org/W2059924414","https://openalex.org/W2083877801","https://openalex.org/W2090230853","https://openalex.org/W2093603669","https://openalex.org/W2100510403","https://openalex.org/W2114671887","https://openalex.org/W2126184332","https://openalex.org/W2131171455","https://openalex.org/W2140467366","https://openalex.org/W2150529860","https://openalex.org/W2154381036","https://openalex.org/W2158308518","https://openalex.org/W2166840599","https://openalex.org/W2168210585","https://openalex.org/W2271790809"],"related_works":["https://openalex.org/W2184664515","https://openalex.org/W2561218821","https://openalex.org/W2548541202","https://openalex.org/W2126184332","https://openalex.org/W2033080849","https://openalex.org/W1985566805","https://openalex.org/W2045721684","https://openalex.org/W2559507552","https://openalex.org/W2056179067","https://openalex.org/W3035919630"],"abstract_inverted_index":{"The":[0,67,206],"purpose":[1],"of":[2,14,32,69,83,89,91,102,135,166,198,203,208,221,223,228],"this":[3,209],"randomized,":[4],"multicenter,":[5],"open-label":[6],"study":[7,210],"was":[8,129],"to":[9,40,64],"compare":[10],"the":[11,17,70,73,103,107,111,121,141,164,177,183,204,226],"continuous":[12,108,178,212],"infusion":[13,20,109,179,213],"piperacillin-tazobactam":[15,41,224],"with":[16,25,77,106],"standard":[18],"intermittent":[19,112,184],"in":[21,72,131,140,148,163,195,200],"262":[22],"hospitalized":[23],"patients":[24,36,71,104,136,167,175,199],"complicated":[26,229],"intra-abdominal":[27,230],"infections.":[28],"Within":[29],"1":[30],"day":[31],"surgical":[33],"intervention,":[34],"eligible":[35],"were":[37,75,115,153,172,189,193],"randomized":[38],"(1:1)":[39],"12":[42],"g/1.5":[43],"g":[44,53],"administered":[45,54],"continuously":[46],"over":[47,55],"24":[48],"h":[49,61],"or":[50,118],"3":[51,169],"g/0.375":[52],"30":[56],"min":[57],"intermittently":[58],"every":[59],"6":[60],"for":[62,225],"4":[63],"14":[65],"days.":[66,93],"demographics":[68],"groups":[74],"similar,":[76],"a":[78,86,215],"median":[79,87],"APACHE":[80],"II":[81],"score":[82],"7":[84,92],"and":[85,100,110,133,145,156,171,180,192,217],"length":[88],"hospitalization":[90],"Among":[94],"167":[95],"clinically":[96,116],"evaluable":[97],"patients,":[98],"86.4%":[99],"88.4%":[101],"treated":[105],"infusion,":[113],"respectively,":[114,144],"cured":[117],"improved":[119],"at":[120],"test-of-cure":[122],"visit":[123],"(P":[124,137],"=":[125,138],"0.817).":[126],"Bacteriological":[127],"success":[128],"observed":[130],"83.9%":[132],"87.9%":[134],"0.597)":[139],"two":[142],"groups,":[143],"no":[146],"differences":[147],"bacteriological":[149],"response":[150],"by":[151],"pathogen":[152],"noted.":[154],"Defervesence":[155],"white":[157],"blood":[158],"cell":[159],"count":[160],"normalization":[161],"occurred":[162],"majority":[165],"within":[168],"days":[170],"similar":[173,196],"between":[174],"receiving":[176,182],"those":[181],"infusion.":[185],"Drug-related":[186],"adverse":[187],"events":[188],"generally":[190],"mild":[191],"reported":[194],"numbers":[197],"each":[201],"arm":[202],"trial.":[205],"results":[207],"support":[211],"as":[214],"safe":[216],"reasonable":[218],"alternate":[219],"mode":[220],"administration":[222],"treatment":[227],"infection.":[231]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2028964482","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":17}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
